Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2001-8-9
pubmed:abstractText
A series of preclinical tests were undertaken during the developmental process to determine the safety profile of gadoversetamide injection (OptiMARK).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0020-9996
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
401-12
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed-meshheading:11496095-Abnormalities, Drug-Induced, pubmed-meshheading:11496095-Animals, pubmed-meshheading:11496095-Blood Cells, pubmed-meshheading:11496095-Cardiovascular System, pubmed-meshheading:11496095-Contrast Media, pubmed-meshheading:11496095-Dogs, pubmed-meshheading:11496095-Dose-Response Relationship, Drug, pubmed-meshheading:11496095-Drug Evaluation, Preclinical, pubmed-meshheading:11496095-Female, pubmed-meshheading:11496095-Fertility, pubmed-meshheading:11496095-Fetus, pubmed-meshheading:11496095-Injections, Intravenous, pubmed-meshheading:11496095-Lethal Dose 50, pubmed-meshheading:11496095-Magnetic Resonance Imaging, pubmed-meshheading:11496095-Male, pubmed-meshheading:11496095-Mice, pubmed-meshheading:11496095-Mice, Inbred ICR, pubmed-meshheading:11496095-Mutagenesis, pubmed-meshheading:11496095-Organometallic Compounds, pubmed-meshheading:11496095-Pregnancy, pubmed-meshheading:11496095-Rats, pubmed-meshheading:11496095-Rats, Sprague-Dawley, pubmed-meshheading:11496095-Toxicity Tests
pubmed:year
2001
pubmed:articleTitle
Toxicological assessment of gadoversetamide injection (OptiMARK), a new contrast-enhancement agent for use in magnetic resonance imaging.
pubmed:affiliation
Mallinckrodt Imaging, St. Louis, Missouri 63134, USA. jhwible@mkg.com
pubmed:publicationType
Journal Article